Relationship Between Number of Oocytes Retrieved and Embryo Euploidy Rate in Controlled Ovarian Stimulation Cycles
Open Access
- 23 August 2022
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (3) , 865-872
Abstract
This cohort study is aimed to determine if higher number of oocytes retrieved affects the rate of euploidy in the embryos of women undergoing controlled ovarian stimulation (COS) for in vitro fertilization (IVF) with preimplantation genetic testing for aneuploidy (PGT-A). A negative trend between the number of oocytes retrieved and embryo euploidy rate was observed using Visual Analytics software, especially when a higher number of oocytes were retrieved. After regression analysis, patient age was the only variable found to have a statistically significant negative effect (p < 0.0001) on euploidy rate in all regression models. Number of oocytes retrieved was not found to have a statistically significant effect on euploidy rate when analyzed per number of biopsied blastocysts (p = 0.5356), per number of oocytes retrieved (p = 0.1025), and per number of fertilized oocytes (p = 0.7241). The parameter estimates in the linear regression models were negative for number of oocytes retrieved. This study shows a statistically significant effect between patient age and embryo euploidy rate, which is already known. There is some evidence to suggest that higher number of oocytes retrieved may negatively impact the number of euploid embryos per number of oocytes retrieved based on the visual analytic graphs, p value approaching significance, and the negative parameter estimates in the regression models.Keywords
This publication has 11 references indexed in Scilit:
- Follicle size indicates oocyte maturity and blastocyst formation but not blastocyst euploidy following controlled ovarian hyperstimulation of oocyte donorsHuman Reproduction, 2020
- PGR and PTX3 gene expression in cumulus cells from obese and normal weighting women after administration of long-acting recombinant follicle-stimulating hormone for controlled ovarian stimulationArchives of Gynecology and Obstetrics, 2019
- Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman’s age and markers of ovarian reserveArchives of Gynecology and Obstetrics, 2018
- Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cyclesFertility and Sterility, 2017
- Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism–based preimplantation genetic screeningFertility and Sterility, 2016
- Milder is better? advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilizationReproductive Biology and Endocrinology, 2011
- Chromosome 21 mosaic human preimplantation embryos predominantly arise from diploid conceptionsFertility and Sterility, 2005
- A Randomized Comparison of Two Ovarian Stimulation Protocols with Gonadotropin-Releasing Hormone (GnRH) Antagonist Cotreatment forin VitroFertilization Commencing Recombinant Follicle-Stimulating Hormone on Cycle Day 2 or 5 with the Standard Long GnRH Agonist ProtocolThe Journal of Clinical Endocrinology & Metabolism, 2003
- Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a reviewHuman Reproduction Update, 2002
- Superovulation of female mice delays embryonic and fetal developmentHuman Reproduction, 2001